Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by jorjitopon Jul 05, 2018 2:05pm
62 Views
Post# 28273627

RE:RE:RE:RE:RE:DIAGNOS Broadens Collaboration with the Government of Mexico

RE:RE:RE:RE:RE:DIAGNOS Broadens Collaboration with the Government of MexicoI thought we had a big contract concluded with Mexico over a year ago.  Lot's of people were looking for big revenue numbers this year.  As usual, Diagnos disappoints again.  The original deal with Mexico was thanks to an insider connection and Diagnos' insider has left the company.

More deals, more contracts, years go by, and no revenues.

And let's stop with this AI nonsense.  There is no Intelligence here.  This is still just a pattern recognition algorithm, just like it was five years ago.
Bullboard Posts